REQUEST A DEMO
Total
USD $0.00
Search more companies

Zuellig Pharma International Services Company Limited (Thailand)

Main Activities: All Other Business Support Services
Full name: Zuellig Pharma International Services Company Limited Profile Updated: March 31, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Zuellig Pharma International Services Company Limited is an enterprise in Thailand, with the main office in Bangkok , Special Governed District of. It operates in the All Other Business Support Services industry. The company was established on May 23, 2026. The total number of employees is currently 25 (estimated). A growth of 0.62% was recorded in its total assets.

Headquarters
2 Sukhumvit) Road
Bangkok , Special Governed District of; Central Thailand; Postal Code: 10110

Contact Details: Purchase the Zuellig Pharma International Services Company Limited report to view the information.

Basic Information
Total Employees:
Purchase the Zuellig Pharma International Services Company Limited report to view the information.
Financial Auditors:
Purchase the Zuellig Pharma International Services Company Limited report to view the information.
Incorporation Date:
May 23, 2026
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Zuellig Pharma International Services Company Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency THB. Absolute financial data is included in the purchased report.
Total Operating Revenue
61.95%
Operating Profit
256.85%
EBITDA
256.85%
Net Profit/Loss for the Period
N/A
Total Assets
0.62%
Total Equity
0.58%
Return on Equity (ROE)
N/A
Quick Ratio
-41.35%
Cash Ratio
-41.16%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?